Newron Pharmaceuticals SpA 2025 Annual Report with Sustainability Disclosures
Company: Newron Pharmaceuticals SpA
Sector: Professional & technical services
Country: Italy
Year: 2025
Type: Annual Report with Sustainability Disclosures
Pages: 104
The report describes Newron's 2025 progress in initiating both pivotal Phase III ENIGMA-TRS studies for evenamide and expanding related partnerships. It reports 27 employees (FTE) at year-end and an average of 20 training hours per employee. Environmental disclosures include compensation for 102,6 tons of employee-flight CO2 emissions and support for planting 100 trees. The ESG section also highlights adoption of the Italian Gender Equality Certification System and Board-level ESG oversight.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.